Sharia Hernandez - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sharia Hernandez

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Oncoimmunology|February 24, 2025

Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockadePedro Rocha, Rafael Bach, Laura Masfarré, et al.

Science (New York, N.Y.)|May 28, 2026

Pan-cancer spatial atlas of tertiary lymphoid structuresKyung Serk Cho, Yunhe Liu, Guangsheng Pei, et al.

Cancer Cell|July 11, 2025

KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Oncoimmunology|February 24, 2025

Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockadePedro Rocha, Rafael Bach, Laura Masfarré, et al.

Science (New York, N.Y.)|May 28, 2026

Pan-cancer spatial atlas of tertiary lymphoid structuresKyung Serk Cho, Yunhe Liu, Guangsheng Pei, et al.

Cancer Cell|July 11, 2025

KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.

Pageof 3